Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes

Table 1

Metabolic parameters for diabetic Ren-2 rats treated with vehicle or vandetanib.

	Vehicle	Vandetanib
Body weight (g)	336±10	296±15
Blood glucose (mmol/L)	27.6±1.2	27.1±1.3
Systolic BP (mmHg)	205±10	224±13
GFR (mL/min/kg)	16.7±0.7	15.2±0.5